Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jacob Vine"'
Autor:
Ari Moskowitz, Michael W Donnino, Anne V Grossestreuer, Katherine M Berg, Long Ngo, Xiaowen Liu, Jacob Vine, Shivani Mehta, Lakshman Balaji, Noa Berlin, Meredith Shea
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Introduction Diabetic ketoacidosis (DKA) is a potentially life-threatening diabetic complication. Despite the high prevalence of DKA and the substantial associated healthcare burden, limited research on strategies to improve outcomes currently exists
Externí odkaz:
https://doaj.org/article/0ad714e2efaa482fad6386d9cc2d3364
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0277618 (2022)
ObjectivesChest X-ray (CXR) is routinely required for assessing Central Venous Catheter (CVC) tip position after insertion, but there is limited data as to the movement of the tip location during hospitalization. We aimed to assess the migration of C
Externí odkaz:
https://doaj.org/article/e30cd3f9404b4d58a3098e4a330c3cad
Autor:
Aviram Hochstadt, Barak Cohen, Ariel Banai, Yaron Arbel, Merav Ingbir, Jacob Vine, Yoav Granot, Shirley Friedman, Tomer Mann, Or Goren, Yishay Szekely, Amir Gal Oz, Yan Topilsky, Idit Matot, Philippe Taieb, Yael Lichter, Yoel Angel, Ilan Merdler, Orly Sapir, Nimrod Adi, Michal Laufer-Perl
Publikováno v:
Intensive Care Medicine
Purpose Information regarding the use of lung ultrasound (LUS) in patients with Coronavirus disease 2019 (COVID-19) is quickly accumulating, but its use for risk stratification and outcome prediction has yet to be described. We performed the first sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd68a79f8eb076e7c4405273dd56242d
https://doi.org/10.1007/s00134-020-06212-1
https://doi.org/10.1007/s00134-020-06212-1
Autor:
Asaph Nini, Jacob Vine, Amir Gal-Oz, Yael Lichter, Lilach Zac, Reut Schvartz, Yishay Szekely, Yan Topilsky, Noam Goder
Publikováno v:
Journal of Emergency and Critical Care Medicine. 6:5-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89ceba7bfa8c6511e22fa8ec9151688d
https://doi.org/10.21037/jeccm-21-32
https://doi.org/10.21037/jeccm-21-32
Autor:
Yael Lichter, Asaph Nini, Yishay Szekely, Noam Goder, Reut Schvartz, Lilach Zac, Yan Topilsky, Jacob Vine, Amir Gal-Oz
Publikováno v:
ASVIDE. 8:216-216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff2d3e15970deae3bc0826b4b4d575da
https://doi.org/10.21037/asvide.2021.216
https://doi.org/10.21037/asvide.2021.216
Autor:
Yael Lichter, Asaph Nini, Yishay Szekely, Noam Goder, Reut Schvartz, Lilach Zac, Yan Topilsky, Jacob Vine, Amir Gal-Oz
Publikováno v:
ASVIDE. 8:218-218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a705a261942093c6bce7773c9c9a845f
https://doi.org/10.21037/asvide.2021.218
https://doi.org/10.21037/asvide.2021.218
Autor:
Yael Lichter, Asaph Nini, Yishay Szekely, Noam Goder, Reut Schvartz, Lilach Zac, Yan Topilsky, Jacob Vine, Amir Gal-Oz
Publikováno v:
ASVIDE. 8:217-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7210e20d160e9b8a9887ab0fb0cd610
https://doi.org/10.21037/asvide.2021.217
https://doi.org/10.21037/asvide.2021.217
Publikováno v:
Critical Care Medicine. 48:257-257
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4cefa1eb3d1d421ad59ea86aa5f5356
https://doi.org/10.1097/01.ccm.0000625956.84027.33
https://doi.org/10.1097/01.ccm.0000625956.84027.33
Publikováno v:
Pharmacotherapy. 35(7)
Apixaban, a direct factor Xa inhibitor, is a novel oral anticoagulant (NOAC) indicated for prevention of embolic events in patients with nonvalvular atrial fibrillation. The agent is associated with a lower risk of bleeding compared with vitamin K an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc14af6bcc96334dab6573d05b72a300
https://pubmed.ncbi.nlm.nih.gov/26095120
https://pubmed.ncbi.nlm.nih.gov/26095120
Autor:
Dina Ben-Yehuda, David Lavie, Alexander Gural, Rosa Ruchlemer, Sara Cohen, Moshe E. Gatt, Deborah Rund, Neta Goldschmidt, Jacob Vine, Moshe Levin, Diana Libster
Publikováno v:
Leukemialymphoma. 55(11)
The optimal tyrosine kinase inhibitor for any individual patient with chronic myeloid leukemia (CML) is not predictable. Pharmacogenetic parameters and trough levels of imatinib (IM) have each been independently correlated with response. We therefore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e087b1b4f55569e5a5b3c21351990354
https://pubmed.ncbi.nlm.nih.gov/24684225
https://pubmed.ncbi.nlm.nih.gov/24684225